drug
Xphozah
Marketedupdated 5mo agoby $ARDX ARDELYX, INC.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Oct 17, 2026
15 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (24)
- Nov 26, 2042formulationUS 12539299
- Nov 26, 2042formulationUS 12539299
- Nov 26, 2042formulationUS 12539299
- Nov 26, 2042formulationUS 12539299
- Apr 10, 2034method-of-use (U-3736)US 10272079
- Apr 10, 2034method-of-use (U-381)US 10272079
- Apr 10, 2034method-of-use (U-381)US 10272079
- Apr 10, 2034method-of-use (U-381)US 10940146
- Apr 10, 2034method-of-use (U-3736)US 10940146
- Apr 10, 2034method-of-use (U-381)US 10940146
- Aug 1, 2033compositionUS 8541448
- Aug 1, 2033compositionUS 8541448
- Aug 1, 2033compositionUS 8541448
- Aug 1, 2033compositionUS 8541448
- May 2, 2030method-of-use (U-2626)US 90062813.6y
- Dec 30, 2029compositionUS 120168563.2y
- Dec 30, 2029compositionUS 120168563.2y
- Dec 30, 2029compositionUS 120168563.2y
- Dec 30, 2029compositionUS 120168563.2y
- Dec 30, 2029compositionUS 89693773.2y
- Dec 30, 2029compositionUS 89693773.2y
- Dec 30, 2029compositionUS 89693773.2y
- Dec 30, 2029compositionUS 89693773.2y
- Dec 30, 2029method-of-use (U-2626)US 94088403.2y
FDA exclusivities (3)
- Oct 17, 2026NPNP15d
- Oct 17, 2026NPNP15d
- Oct 17, 2026NPNP15d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that